Kieffer N, Fitzgerald L A, Wolf D, Cheresh D A, Phillips D R
COR Therapeutics Inc., South San Francisco, California 94080.
J Cell Biol. 1991 Apr;113(2):451-61. doi: 10.1083/jcb.113.2.451.
Glycoprotein IIb-IIIa (alpha IIb beta 3) and the vitronectin receptor (alpha v beta 3), two integrins that share the common beta 3 subunit, have been reported to function as promiscuous receptors for the RGD-containing adhesive proteins fibrinogen, vitronectin, fibronectin, von Willebrand factor, and thrombospondin. The present study was designed to establish a cell system for the expression of either GP IIb-IIIa or the vitronectin receptor in an otherwise identical cellular environment and to compare the adhesive properties of these two integrins with those of native GP IIb-IIIa and the vitronectin receptor constitutively expressed in HEL cells or platelets. M21 human melanoma cells lack GP IIb-IIIa and use the vitronectin receptor to attach to vitronectin, fibrinogen, fibronectin, and von Willebrand factor. To study the functional properties of GP IIb-IIIa in these cells, we transfected GP IIb into M21-L cells, a variant of M21 cells (Cheresh, D.A., and R.C. Spiro. 1987. J. Biol. Chem. 262:17703-17711), which lack the expression of functional alpha v and are therefore unable to attach to vitronectin, fibrinogen, and von Willebrand factor. Transfectants expressing GP IIb were isolated by immunomagnetic beads and surface expression of the GP IIb-IIIa complex was documented by FACS analysis and immunoprecipitation experiments performed with 125I-labeled M21-L/GP IIb cells. Comparative functional studies demonstrated that GP IIb-IIIa expressed in M21-L/GPIIb cells as well as native GP IIb-IIIa constitutively expressed in HEL-5J20 cells (an HEL variant lacking alpha v beta 3) mediated cell attachment to immobilized fibrinogen, but not to vitronectin or von Willebrand factor, whereas the vitronectin receptor expressed in M21 cells and HEL-AD1 cells (an HEL variant expressing alpha v beta 3) mediated cell attachment to fibrinogen, vitronectin, and von Willebrand factor. Similarly, PGl2-treated resting platelets attached to immobilized fibrinogen but not to vitronectin or von Willebrand factor, and this attachment could be inhibited by mAb A2A9 (directed against a functional site on the GP IIb-IIIa complex). However, in contrast to platelets, which adhered to vitronectin and von Willebrand factor after stimulation by thrombin or PMA, activation of the protein kinase C pathway in M21-L/GP IIb or HEL cells did not induce cell adhesion to vitronectin or von Willebrand factor.(ABSTRACT TRUNCATED AT 400 WORDS)
糖蛋白IIb-IIIa(αIIbβ3)和玻连蛋白受体(αvβ3)是两种共享共同β3亚基的整合素,据报道它们可作为含RGD黏附蛋白纤维蛋白原、玻连蛋白、纤连蛋白、血管性血友病因子和血小板反应蛋白的混杂受体。本研究旨在建立一个细胞系统,以便在相同的细胞环境中表达GP IIb-IIIa或玻连蛋白受体,并将这两种整合素的黏附特性与在HEL细胞或血小板中组成性表达的天然GP IIb-IIIa和玻连蛋白受体的黏附特性进行比较。M21人黑色素瘤细胞缺乏GP IIb-IIIa,利用玻连蛋白受体附着于玻连蛋白、纤维蛋白原、纤连蛋白和血管性血友病因子。为了研究这些细胞中GP IIb-IIIa的功能特性,我们将GP IIb转染到M21-L细胞中,M21-L细胞是M21细胞的一个变体(Cheresh, D.A., and R.C. Spiro. 1987. J. Biol. Chem. 262:17703-17711),其缺乏功能性αv的表达,因此无法附着于玻连蛋白、纤维蛋白原和血管性血友病因子。通过免疫磁珠分离表达GP IIb的转染子,并用FACS分析和用125I标记的M21-L/GP IIb细胞进行的免疫沉淀实验记录GP IIb-IIIa复合物的表面表达。比较功能研究表明,在M21-L/GPIIb细胞中表达的GP IIb-IIIa以及在HEL-5J20细胞(缺乏αvβ3的HEL变体)中组成性表达的天然GP IIb-IIIa介导细胞附着于固定化的纤维蛋白原,但不附着于玻连蛋白或血管性血友病因子,而在M21细胞和HEL-AD1细胞(表达αvβ3的HEL变体)中表达的玻连蛋白受体介导细胞附着于纤维蛋白原、玻连蛋白和血管性血友病因子。同样,经PGl2处理的静息血小板附着于固定化的纤维蛋白原,但不附着于玻连蛋白或血管性血友病因子,并且这种附着可被mAb A2A9(针对GP IIb-IIIa复合物上的一个功能位点)抑制。然而,与血小板不同,血小板在凝血酶或PMA刺激后附着于玻连蛋白和血管性血友病因子,在M21-L/GP IIb或HEL细胞中蛋白激酶C途径的激活并未诱导细胞附着于玻连蛋白或血管性血友病因子。(摘要截短于400字)